Author

Thomas Bienvenu

Centre Hospitalier Charles PerrensORCID 0000-0002-7416-0504Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Thomas Bienvenu1 paper · Inserm

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

Cyril DéjeaniD· 1 shared Cyril HerryiD· 1 shared Delphine GirardiD· 1 shared Eleonore KurekiD· 1 shared Frédéric LanoreiD· 1 shared Jean‐Baptiste VerlhaciD· 1 shared Jérémy LesasiD· 1 shared Jonathan DanieliD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Cyril DéjeanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Dye-based Fluorescent Organic Nanoparticles, New Promising Tools for Optogenetics

Jérémy Lesas, Thomas Bienvenu, Eleonore Kurek, Jean‐Baptiste Verlhac, Zoé Grivet, Maude Têtu, Delphine Girard, Frédéric Lanore, Mireille H. Blanchard-Desce, Cyril Herry, Jonathan Daniel, Cyril Déjean

This paper demonstrates dye-based fluorescent organic nanoparticles can activate Chrimson opsin in vivo and reduce fear in mice through optogenetic stimulation.

Advanced Healthcare Materials · Sep 12, 2024Peer-reviewedNeuroscience